{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:40:08Z","timestamp":1768549208132,"version":"3.49.0"},"reference-count":29,"publisher":"IMR Press","issue":"10","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program \u201cPrecision Medicine Research\u201d Key Special Project","award":["2017YFC0909000"],"award-info":[{"award-number":["2017YFC0909000"]}]},{"name":"National Natural Science Foundation Youth Project","award":["71804109"],"award-info":[{"award-number":["71804109"]}]},{"name":"\u201cRising Stars of Medical Talents\u201d Youth Development Program-Youth Medical Talents","award":["SHWSRS(2021)_099"],"award-info":[{"award-number":["SHWSRS(2021)_099"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: To evaluate the concordance between QuantiFERON-TB Gold in-tube test (QFT-GIT) and T-SPOT.TB test (T-SPOT) for the screening of latent tuberculosis infection (LTBI) in patients with rheumatic diseases (RDs). Methods: Patients diagnosed as rheumatic diseases (RDs) with clinical indications for test of interferon gamma release test (IGRA) were prospectively recruited from 2019 to 2020. The consistency of QFT-GIT and T-SPOT was assessed by Kappa analysis and the factors associated with the indeterminate results were explored by multivariable logistic analysis. Results: A total of 108 patients with RDs were enrolled, including 64 patients with systemic lupus erythematosus (SLE) and 44 with inflammatory arthritis (26 with rheumatoid arthritis (RA) and 18 with ankylosing spondylitis (AS)). Poor concordance was confirmed between QFT-GIT and T-SPOT results in patients with SLE (K = 0.175, 95% confidence interval [95% CI] [\u20130.06, 0.40], p &lt; 0.001), whereas concordance was moderate in patients with inflammatory arthritis (K = 0.539, 95% CI [0.11, 0.88], p &lt; 0.001). Among SLE patients, the ratio of indeterminate results in detecting LTBI was significantly higher by QFT-GIT than by T-SPOT (18.8% vs. 4.7%, p = 0.013), while the statistical difference was not achieved in patients with inflammatory arthritis. The multivariable logistic analysis identified that the presence of lower lymphocyte counts (odds ratio [OR] = 0.81, 95% CI [0.68, 0.97], p = 0.020) was the independent predictor of an indeterminate result of the QFT-GIT in SLE patients. Conclusions: In patients with RDs, the result of screening of LTBI was more definitive by T-SPOT test than QFT, and the concordance was poor especially in the setting of SLE.<\/jats:p>","DOI":"10.31083\/j.fbl2710282","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T06:37:11Z","timestamp":1665470231000},"source":"Crossref","is-referenced-by-count":4,"title":["Performance of LTBI Screening in Patients with Rheumatic Diseases Using Two Different Interferon-Gamma Releasing Assays"],"prefix":"10.31083","volume":"27","author":[{"given":"Le","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"},{"name":"Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjing","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200002 Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Yang Y, Thumboo J, Tan BH, Tan TT, Fong CHJ, Ng HS, et al. The risk of tuberculosis in SLE patients from an Asian tertiary hospital. Rheumatology International. 2017; 37: 1027\u20131033.","DOI":"10.1007\/s00296-017-3696-3"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Arkema EV, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, Askling J. ARTIS Study Group. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? Annals of The Rheumatic Diseases. 2015; 74: 1212\u20131217.","DOI":"10.1136\/annrheumdis-2013-204960"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmunity Reviews. 2008; 8: 24\u201328.","DOI":"10.1016\/j.autrev.2008.07.019"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Xiao X, Da G, Xie X, Liu X, Zhang L, Zhou B, et al. Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study. Journal of Internal Medicine. 2021; 290: 101\u2013115.","DOI":"10.1111\/joim.13218"},{"key":"ref5","unstructured":"World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. World Health Organization: Geneva. 2015."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. Lupus. 2012; 21: 491\u2013495.","DOI":"10.1177\/0961203311430700"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Takeda N, Nojima T, Terao C, Yukawa N, Kawabata D, Ohmura K, et al. Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus. Lupus. 2011; 20: 792\u2013800.","DOI":"10.1177\/0961203310397966"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sarg\u0131n G, \u015eent\u00fcrk T, Ceylan E, Telli M, \u00c7ilda\u011f S, Do\u011fan H. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy. T\u00fcberk\u00fcloz Ve Toraks. 2018; 66: 136\u2013143.","DOI":"10.5578\/tt.66444"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Arenas Miras Mdel M, Hidalgo-Tenorio C, Jimenez-Gamiz P, Jim\u00e9nez-Alonso J. Diagnosis of latent tuberculosis in patients with systemic lupus erythematosus: T.SPOT.TB versus tuberculin skin test. Biomed Research International. 2014; 2014: 291031.","DOI":"10.1155\/2014\/291031"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ruan Q, Zhang S, Ai J, Shao L, Zhang W. Screening of latent tuberculosis infection by interferon-\u03b3 release assays in rheumatic patients: a systemic review and meta-analysis. Clinical Rheumatology. 2016; 35: 417\u2013425.","DOI":"10.1007\/s10067-014-2817-6"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Anton C, Machado FD, Ramirez JMA, Bernardi RM, Palominos PE, Brenol CV, et al. Latent tuberculosis infection in patients with rheumatic diseases. Jornal Brasileiro de Pneumologia. 2019; 45: e20190023.","DOI":"10.1590\/1806-3713\/e20190023"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of The Rheumatic Diseases. 2019; 78: 1151\u20131159.","DOI":"10.1136\/annrheumdis-2018-214819"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatology. 2010; 62: 2569\u20132581.","DOI":"10.1002\/art.27584"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Annals of The Rheumatic Diseases. 2011; 70: 25\u201331.","DOI":"10.1136\/ard.2010.133645"},{"key":"ref15","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. The Journal of Rheumatology. 2002; 29: 288\u2013291."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, et al. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection. Journal of Clinical Microbiology. 2019; 57: e00985-19.","DOI":"10.1128\/JCM.00985-19"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Gaffney RG, Werth VP. Evaluating results of an interferon-\u03b3 release assay in patients with autoimmune disease who are taking hydroxychloroquine. Journal of The American Academy of Dermatology. 2019; 80: 1162\u20131164.","DOI":"10.1016\/j.jaad.2018.12.027"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine. 2008; 149: 177\u2013184.","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Kim JH, Cho SK, Han M, Choi CB, Kim TH, Jun JB, et al. Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases. Seminars in Arthritis and Rheumatism. 2013; 42: 424\u2013432.","DOI":"10.1016\/j.semarthrit.2012.07.001"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Cho H, Kim YW, Suh CH, Jung JY, Um YJ, Jung JH, et al. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA. Lupus. 2016; 25: 1341\u20131348.","DOI":"10.1177\/0961203316639381"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Matsumura R, Igari H, Nakazawa T, Ishikawa S, Tsuyuzaki M, Suzuki K, et al. Comparative utility of interferon-\u03b3 release assay, QuantiFERON\u00ae TB-GIT and T-SPOT\u00ae.TB in rheumatoid arthritis. International Journal of Tuberculosis and Lung Disease. 2016; 20: 1546\u20131553.","DOI":"10.5588\/ijtld.16.0038"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Nozawa T, Mori M, Nishimura K, Sakurai N, Kikuchi M, Hara R, et al. Usefulness of two interferon-\u03b3 release assays for rheumatic disease. Pediatrics International. 2016; 58: 347\u2013352.","DOI":"10.1111\/ped.12885"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Maharani W, Ratnaningsih DF, Utami F, Yulianto FA, Dewina A, Hamijoyo L, et al. Activity Disease in SLE Patients Affected IFN-\u03b3 in the IGRA Results. Journal of Inflammation Research. 2020; 13: 433\u2013439.","DOI":"10.2147\/JIR.S258235"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Rousset S, Treiner E, Moulis G, Pugnet G, Astudillo L, Paricaud K, et al. High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis. Rheumatology. 2020; 59: 1006\u20131010.","DOI":"10.1093\/rheumatology\/kez390"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Dai Q, Qiao K, Zhang S, Huo Z, Wang J, Qi C, et al. Influential Factors of the Indeterminate Results Tested by QuantiFERON-TB Gold In-Tube (QFT-IT) Assay for Diagnosing TB Infection in HIV-Infected Patients. Clinical Laboratory. 2016; 62: 1761\u20131766.","DOI":"10.7754\/Clin.Lab.2016.160209"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Jeong SJ, Han SH, Kim CO, Baek JH, Jin SJ, Ku NS, et al. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country. Journal of Infection. 2011; 62: 347\u2013354.","DOI":"10.1016\/j.jinf.2011.03.004"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Calabrese C, Overman RA, Dusetzina SB, Hajj-Ali RA. Evaluating Indeterminate Interferon-\u03b3-Release Assay Results in Patients With Chronic Inflammatory Diseases Receiving Immunosuppressive Therapy. Arthritis Care & Research. 2015; 67: 1063\u20131069.","DOI":"10.1002\/acr.22454"},{"key":"ref28","unstructured":"P\u00e9rez Catal\u00e1n I, Roig Mart\u00ed C, Gil Fortu\u00f1o M, Torrent Ramos P, Albiol Vi\u00f1als P, Carballido Fern\u00e1ndez M, et al. Concordance between the test of the tuberculin and Interferon Gamma Release Assay-IGRA in patients with immune-mediated inflammatory diseases. Revista Espanola de Quimioterapia. 2019; 32: 445\u2013450. (In Spanish)"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Jung HJ, Kim TJ, Kim HS, Cho YN, Jin HM, Kim MJ, et al. Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases. Rheumatology International. 2014; 34: 1711\u20131720.","DOI":"10.1007\/s00296-014-3033-z"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/10\/10.31083\/j.fbl2710282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:13:24Z","timestamp":1732709604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/10\/10.31083\/j.fbl2710282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2768-6701(22)00626-8"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2710282","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"article-number":"282"}}